About
Encapsulated Cell Therapy
Areas of Focus
Categories
Stem Cell & Cellular TherapyDrug Delivery & FormulationBoston & New England
Team (3)
Clinical Trials (28)
View allTotal Trials
28
As Lead Sponsor
23
As Collaborator
5
Total Enrollment
4,057
By Phase
PHASE4: 5PHASE3: 3PHASE2: 10PHASE1/PHASE2: 3PHASE1: 2NA: 1PHASE2/PHASE3: 3
By Status
COMPLETED: 19TERMINATED: 5NOT_YET_RECRUITING: 1ACTIVE_NOT_RECRUITING: 1UNKNOWN: 1AVAILABLE: 1
Clinical Trials Pipeline27 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Today
Hover over trial bars to see details
Recent Trials
NCT06971939Lead Sponsor
Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants
PHASE4Not yet recruiting
285 participants
Started: Aug 15, 2025 · Completed: Aug 15, 2030
NCT06397131Lead Sponsor
A Study to Determine the Safety and Efficacy of NT-501 With MHFM
PHASE3Active, not recruiting
12 participants
Started: Mar 6, 2025 · Completed: Jul 24, 2026
NCT04729972Lead Sponsor
Safety Study to Evaluate Bilateral CNTF Implants in Subjects With MacTel Type 2
PHASE2Completed
33 participants
Started: Jul 21, 2021 · Completed: Dec 8, 2022
NCT03319849Lead Sponsor
A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol B
PHASE3Completed
119 participants
Started: Jan 22, 2018 · Completed: Sep 23, 2022
NCT03316300Lead Sponsor
A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol A
PHASE3Completed
120 participants
Started: Nov 24, 2017 · Completed: Sep 23, 2022
Locations (1)
Headquarters
Cumberland, RI, United States
Map
Loading map...